Highland Capital Management (Tennessee)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,236
| Closed | -$2.9M | – | 413 |
|
|
2024
Q3 | $2.9M | Sell |
6,236
-239
| -4% | -$111K | 0.17% | 143 |
|
|
2024
Q2 | $3.03M | Sell |
6,475
-1,256
| -16% | -$589K | 0.18% | 138 |
|
|
2024
Q1 | $3.23M | Buy |
7,731
+35
| +0.5% | +$14.6K | 0.19% | 141 |
|
|
2023
Q4 | $3.13M | Sell |
7,696
-25
| -0.3% | -$10.2K | 0.19% | 141 |
|
|
2023
Q3 | $2.68M | Sell |
7,721
-112
| -1% | -$38.9K | 0.18% | 146 |
|
|
2023
Q2 | $2.76M | Sell |
7,833
-58
| -0.7% | -$20.4K | 0.18% | 146 |
|
|
2023
Q1 | $2.49M | Sell |
7,891
-185
| -2% | -$58.3K | 0.18% | 140 |
|
|
2022
Q4 | $2.33M | Sell |
8,076
-68
| -0.8% | -$19.6K | 0.16% | 152 |
|
|
2022
Q3 | $2.36M | Buy |
8,144
+10
| +0.1% | +$2.9K | 0.18% | 142 |
|
|
2022
Q2 | $2.29M | Hold |
8,134
| – | – | 0.16% | 153 |
|
|
2022
Q1 | $2.12M | Buy |
8,134
+54
| +0.7% | +$14.1K | 0.13% | 171 |
|
|
2021
Q4 | $1.77M | Sell |
8,080
-2
| -0% | -$439 | 0.1% | 203 |
|
|
2021
Q3 | $1.47M | Sell |
8,082
-858
| -10% | -$156K | 0.09% | 215 |
|
|
2021
Q2 | $1.8M | Sell |
8,940
-276
| -3% | -$55.7K | 0.11% | 193 |
|
|
2021
Q1 | $1.98M | Sell |
9,216
-777
| -8% | -$167K | 0.12% | 187 |
|
|
2020
Q4 | $2.36M | Sell |
9,993
-443
| -4% | -$105K | 0.15% | 162 |
|
|
2020
Q3 | $2.84M | Buy |
10,436
+136
| +1% | +$37K | 0.2% | 132 |
|
|
2020
Q2 | $2.99M | Buy |
10,300
+918
| +10% | +$266K | 0.23% | 118 |
|
|
2020
Q1 | $2.23M | Buy |
+9,382
| New | +$2.23M | 0.21% | 117 |
|
|
2018
Q3 | – | Sell |
-3,198
| Closed | -$544K | – | 358 |
|
|
2018
Q2 | $544K | Sell |
3,198
-44
| -1% | -$7.49K | 0.04% | 288 |
|
|
2018
Q1 | $528K | Buy |
3,242
+460
| +17% | +$74.9K | 0.04% | 282 |
|
|
2017
Q4 | $417K | Buy |
2,782
+116
| +4% | +$17.4K | 0.03% | 300 |
|
|
2017
Q3 | $405K | Buy |
+2,666
| New | +$405K | 0.03% | 286 |
|